Skip NavigationSkip to Content

Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines

  1. Author:
    Nagel, S.
    Venturini, L.
    Marquez, V. E.
    Meyer, C.
    Kaufmann, M.
    Scherr, M.
    MacLeod, R. A. F.
    Drexler, H. G.
  2. Author Address

    [Nagel, Stefan; Meyer, Corinna; Kaufmann, Maren; MacLeod, Roderick A. F.; Drexler, Hans G.] DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Lines, D-38124 Braunschweig, Germany. [Venturini, Letizia; Scherr, Michaela] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-30125 Hannover, Germany. [Marquez, Victor E.] NCI, NIH, Med Chem Lab, Frederick, MD 21701 USA.;Nagel, S, DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Lines, Inhoffenstr 7B, D-38124 Braunschweig, Germany.;sna@dsmz.de
    1. Year: 2010
    2. Date: Jun
  1. Journal: Molecular Cancer
    1. 9
    2. Pages: 12
  2. Type of Article: Article
  3. Article Number: 151
  4. ISSN: 1476-4598
  1. Abstract:

    Background: NK- and T-cells are closely related lymphocytes, originating from the same early progenitor cells during hematopoiesis. In these differentiation processes deregulation of developmental genes may contribute to leukemogenesis. Here, we compared expression profiles of NK- and T-cell lines for identification of aberrantly expressed genes in T-cell acute lymphoblastic leukemia (T-ALL) which physiologically regulate the differentiation program of the NK-cell lineage. Results: This analysis showed high expression levels of HOXA9, HOXA10 and ID2 in NK-cell lines in addition to T-cell line LOUCY, suggesting leukemic deregulation therein. Overexpression experiments, chromatin immuno-precipitation and promoter analysis demonstrated that HOXA9 and HOXA10 directly activated expression of ID2. Concomitantly elevated expression levels of HOXA9 and HOXA10 together with ID2 in cell lines containing MLL translocations confirmed this form of regulation in both ALL and acute myeloid leukemia. Overexpression of HOXA9, HOXA10 or ID2 resulted in repressed expression of apoptosis factor BIM. Furthermore, profiling data of genes coding for chromatin regulators of homeobox genes, including components of polycomb repressor complex 2 (PRC2), indicated lacking expression of EZH2 in LOUCY and exclusive expression of HOP in NK-cell lines. Subsequent treatment of T-cell lines JURKAT and LOUCY with DZNep, an inhibitor of EZH2/PRC2, resulted in elevated and unchanged HOXA9/10 expression levels, respectively. Moreover, siRNA-mediated knockdown of EZH2 in JURKAT enhanced HOXA10 expression, confirming HOXA10-repression by EZH2. Additionally, profiling data and overexpression analysis indicated that reduced expression of E2F cofactor TFDP1 contributed to the lack of EZH2 in LOUCY. Forced expression of HOP in JURKAT cells resulted in reduced HOXA10 and ID2 expression levels, suggesting enhancement of PRC2 repression. Conclusions: Our results show that major differentiation factors of the NK-cell lineage, including HOXA9, HOXA10 and ID2, were (de) regulated via PRC2 which therefore contributes to T-cell leukemogenesis.

    See More

External Sources

  1. DOI: 10.1186/1476-4598-9-151
  2. WOS: 000280187900001

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel